ITFISA
EW icon

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Edwards Lifesciences EW Stock Holding History

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Hold
130
– – ﹤0.01% 196
2026
Q1 		$10.4K Buy
+130
New +$10.7K ﹤0.01% 190

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's EW Position: Q2 2026 in Review

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna held its Edwards Lifesciences (EW) position steady in Q2 2026 at 130 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #196.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in EW in Q1 2026 and has held it in 2 quarters since. 1,042 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna held 130 shares of Edwards Lifesciences worth $11.8K as of Q2 2026.
  • Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's portfolio in Q2 2026, its #196 holding.
  • Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in Edwards Lifesciences in Q1 2026 and has held it in 2 quarters since.
  • 1,042 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's 13F filing for Q2 2026, filed 21 Jul 2026.